NCT06727734View on ClinicalTrials.gov

Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

980

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

October 31, 2027

Conditions
Contraception
Interventions
DRUG

Levonorgestrel

Levonorgestrel 1.5 mg

DRUG

Piroxicam

Piroxicam 40 mg

DRUG

Ulipristal Acetate

Ulipristal 30 mg

DRUG

Placebo - LNG

Placebo of levonorgestrel

DRUG

Placebo - Piroxicam

Placebo of piroxicam

DRUG

Placebo - UPA

Placebo of ulipristal acetate

All Listed Sponsors
collaborator

The Family Planning Association of Hong Kong

OTHER

lead

The University of Hong Kong

OTHER